FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 浙江三花智能控制股份有限公司 呈交日期： 2025年11月14日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 | 否 | | | | 證券代號 (如上市) | 002050 | 說明 | A股 (於深圳證券交易所上市) | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | ...

Market Performance - The Hang Seng Index increased by 1.26% this week, closing at 26,572.46 points, while the Tech Index decreased by 0.42% to 5,812.80 points, and the National Enterprises Index rose by 1.41% to 9,397.96 points [2][4]. Market Dynamics - The fluctuations in the Hong Kong stock market are closely related to external environments, particularly the impact of the U.S. government shutdown, which temporarily locked nearly one trillion dollars in liquidity, raising the cost of dollar funds and pressuring risk assets like U.S. and Hong Kong stocks [4]. - A recent report from Western Securities suggests that the end of the U.S. government shutdown may release previously "frozen" dollar liquidity, potentially leading to a liquidity-driven rally in the Hong Kong stock market [4]. Capital Inflows - Southbound capital has provided strong support, with net purchases through the Stock Connect exceeding HKD 1.3 trillion this year, totaling over HKD 5 trillion, indicating a shift towards a "semi-onshore market" where domestic capital plays a more significant role in pricing [4]. Sector Performance - Pharmaceutical stocks have seen renewed interest, with notable gains: - Gilead Sciences (01672.HK) up 45.40% - Clover Biopharmaceuticals (02197.HK) up 29.95% - Yummy (02589.HK) up 18.81% - The positive performance is attributed to strong Q3 results in innovative drugs and life sciences sectors [5]. - Other notable performers include: - HuShang Ayi (02589.HK) up 31.44% due to a new ten-year H-share incentive plan and reaching over 10,739 stores [5]. - Lee & Man Paper (00746.HK) up 17.37% benefiting from rising paper prices [5]. - Conversely, companies like Sanhua Intelligent Control (02050.HK) and Legend Holdings (06683.HK) faced declines of 10.93% and 19.82%, respectively, due to market risk aversion and concerns over equity dilution from a recent share placement [5]. Gold and Automotive Sectors - Gold stocks weakened following hawkish comments from Federal Reserve officials, with China Gold International (02099.HK) down 3.94% and Zijin Mining (02899.HK) down 2.94% [6][7]. - The automotive sector also faced declines, with Xpeng Motors (09868.HK) down 6.80% amid a drop in retail sales of passenger cars by 19% year-on-year for the first nine days of November [10][11]. Brokerage and Semiconductor Stocks - Chinese brokerage stocks adjusted, with major firms like GF Securities (01776.HK) and China Galaxy (06881.HK) experiencing declines due to a significant drop in new account openings [13]. - Semiconductor stocks also fell, influenced by a broader sell-off in U.S. tech stocks, with Shanghai Fudan (01385.HK) down 5.92% and SMIC (00981.HK) down 2.78% [14][16]. Individual Stock Movements - Lehua Entertainment (02306.HK) rose nearly 8% amid speculation regarding a contract renewal with a prominent artist [18]. - Zhonghui Biopharmaceuticals (02627.HK) increased by over 6% after announcing the initiation of Phase I clinical trials for its flu vaccines [19].

Core Viewpoint - Sanhua Intelligent Control (02050) has seen a decline of over 5%, retreating more than 20% from its year-to-date high, with a current trading price of 33.82 HKD and a transaction volume of 533 million HKD [1] Group 1: Company Performance - Sanhua Intelligent Control's stock dropped by 5.05% as of the latest report [1] - The company has recently been involved in rumors regarding a significant order from Tesla, which it denied, stating it has not secured any large orders [1] Group 2: Industry Insights - Goldman Sachs conducted a field research report on the Chinese humanoid robot supply chain from November 3 to 6, surveying nine companies, including Sanhua Intelligent Control [1] - The report indicates that these companies are actively planning production capacity both domestically and internationally, with annual capacity planning ranging from 100,000 to 1 million units of robot equivalents [1] - Goldman Sachs forecasts a global shipment of 1.38 million units by 2035, reflecting an optimistic outlook on the industry's growth potential [1] - None of the surveyed companies confirmed any substantial orders or provided a clear mass production timeline [1] Group 3: Strategic Developments - Sanhua Intelligent Control is focusing on its "thermal management" core technology to expand into the robotics business [1] - The company has acquired approximately 200,000 square meters of land in Thailand specifically for humanoid robot actuator assembly, and has initiated production capacity at this site [1]

Core Viewpoint - Sanhua Intelligent Control (02050.HK) announced a private arrangement to repurchase 912,000 A-shares at a cost of RMB 9.93 million, with a repurchase price range of RMB 9.05 to 11.4 per share [1] Summary by Category - **Company Actions** - The company plans to repurchase a total of 912,000 A-shares [1] - The total expenditure for the repurchase is RMB 9.93 million [1] - The repurchase price per share is set between RMB 9.05 and 11.4 [1]

Group 1 - The company, Sanhua Intelligent Control (stock code: 02050), announced a share buyback plan involving a total expenditure of 9.9315 million yuan to repurchase 912,000 A-shares [1]

翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 FF305 公司名稱： 浙江三花智能控制股份有限公司 呈交日期： 2025年11月13日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | A | 於香港聯交所上市 | 否 | | | 證券代號 (如上市) | 002050 | 說明 | A股 (於深圳證券交易所上市) | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 佔有關事件前的現有已發 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部或任何部分內容所產生或因依賴該等內容而引致的任何損失承擔任何責任。 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：2050） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條 而 做 出。 茲載列浙江三花智能控制股份有限公司於深圳證券交易所網站(www.szse.cn)刊 登 的 公 告 如 下，僅 供 參 閱。 承董事會命 浙江三花智能控制股份有限公司 董事長兼執行董事 張亞波 香 港，2025 年11月13日 於本公告日 期，董事會包 括 (i)執行董事張亞波先 生、王大勇先 生、倪曉明先生 及陳雨忠先 生；(ii)非執行董事張少波先生及任金土先生 及 (iii)獨立非執行董事 鮑恩斯先 生、石建輝先 生、潘亞嵐女士以及葛俊先 生。 ZHEJIANG SANHUA INTELLIGENT CONTROLS CO., LTD. 浙江三 ...

Summary of the Conference Call on Asia Emerging Robotics Industry Overview - **Industry**: Humanoid Robotics - **Growth Forecast**: The humanoid robot industry is expected to grow significantly, with annual shipments projected to reach approximately 1 million units by 2031 (Total Addressable Market: ~USD 20 billion) and around 50 million units by 2050 (Total Addressable Market: ~USD 800 billion) [2][34] Key Companies Covered - **Shuanghuan**: Rated Outperform, recognized as a global leader in gears and reducers, well-prepared for the humanoid era [8][20] - **Hesai**: Rated Outperform, a frontrunner in "laser eyes" technology, expected to benefit from intelligent vehicles and robotics [11][20] - **Tuopu**: Rated Outperform, a leading auto parts supplier with strong capabilities in robotics [11][20] - **Sanhua**: Rated Market-Perform, has a high-quality core business but limited robotics experience [11][20] - **Leader Drive**: Rated Underperform, concerns over long-term market share and margins [11][20] Core Insights - **Investment Strategy**: Emphasizes investing in companies with broad robotics exposure, proven expertise expansion, and high-quality core businesses. The overarching theme is to "Make No Bet" on specific humanoid robots due to the industry's early-stage nature [4][7][64] - **China's Advantage**: China is positioned as a leader in the humanoid robot industry, benefiting from rapid product iteration, a broad user base, and a well-established supply chain. The approach contrasts with Western companies, which often pursue idealistic solutions [3][34][48] Market Dynamics - **Technological Maturity**: The humanoid robot industry is still evolving, with significant technological barriers remaining, particularly in robotic intelligence and cost [33][34] - **Competition**: The industry faces challenges from non-humanoid robots, which are already deployed in various applications. This competition may impact the adoption and market share of humanoid robots [64][78] Investment Recommendations - **Characteristics of Target Companies**: 1. **Upstream Winners**: Focus on key component suppliers rather than downstream players, as the latter are still too early to identify [9][66] 2. **Broad Robotics Exposure**: Companies should have capabilities beyond humanoid robots to mitigate risks from competition [9][66] 3. **Expertise Expansion**: Companies with a strong ability to adapt to technological changes are preferred [9][66] 4. **High-Quality Core Businesses**: Essential for sustainable cash flows and reasonable valuations [9][66] Conclusion - The humanoid robot industry presents substantial long-term potential, with significant growth expected in the coming decades. Investment strategies should focus on established companies with diversified capabilities and a strong market presence to navigate the evolving landscape effectively [7][64][66]

Market Overview - The Hang Seng Index rose by 0.61%, gaining 161 points to close at 26,406 points, while the Hang Seng Tech Index increased by 0.12%. The morning trading volume in Hong Kong reached 114.1 billion HKD [1]. Company Highlights - China Duty Free Group (601888) (01880) saw a surge of over 13% as the new duty-free policy in Hainan shows positive effects, with institutions suggesting a potential industry turning point [1]. - Pop Mart (09992) increased by over 6% due to gradual capacity expansion, with management expecting stronger sales performance in Q4 [1]. - Dongyang Sunshine Pharmaceutical (600673) (06887) rose by over 4% as flu activity is on the rise, and institutions are optimistic about the company's innovative pipeline development [1]. - China Liansu (02128) gained over 5% as the company is expected to benefit significantly from urban pipeline upgrades under the 14th Five-Year Plan [1]. - Hou Shang Ayi (02589) increased by over 8% after the company proposed adopting an H-share incentive plan, successfully entering the "10,000-store club" [1]. - Education stocks performed well, with institutions noting overall good performance in the education sector and the potential for AI+ education to enhance valuation. China Education Holdings (00839) rose by 8%, Thinking Academy (01769) by 3.3%, and New Oriental-S (09901) by 3.25% [1]. - Ruipu Lanjun (00666) increased by over 6% as global demand for energy storage remains strong, with the company reporting over 50 GWh of energy storage battery shipments in the first three quarters [1]. - Gilead Sciences-B (01672) rose by over 6% after being included in the MSCI Global Small Cap Index, with significant weight loss effects from ASC30 [1]. - Goldwind Technology (002202) (02208) fell by over 5% as a major shareholder, Harmony Health, plans to further reduce its stake by up to 1%, following a previous reduction at the end of last month [1]. - Robotics concept stocks declined, with DCH Holdings (00179) dropping over 4% and Sanhua Intelligent Controls (002050) (02050) falling over 3% [1].

Group 1 - The core viewpoint is that Hong Kong's robotics concept stocks are experiencing a decline, with specific companies showing significant drops in their stock prices [1][2] Group 2 - DCH Holdings (00179.HK) has seen a decrease of 6.06%, trading at 33.16 HKD [1] - Sanhua Intelligent Control (02050.HK) has dropped by 3.56%, with a current price of 36.34 HKD [1]